Foghorn Therapeutics Inc. (FHTX)
USD 3.48
(7.74%)
USD 3.48
(7.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 34.15 Million | 19.22 Million | 1.31 Million | 430 Thousand | - | - |
| Cost of Revenue | 109.68 Million | 19.22 Thousand | 7.51 Million | 57.71 Million | 1.79 Million | 379 Thousand |
| Gross Profit | -75.53 Million | 19.2 Million | -6.19 Million | -57.28 Million | -1.79 Million | -379 Thousand |
| Operating Expenses | 142.06 Million | 136.36 Million | 102.05 Million | 68.96 Million | 51.08 Million | 26.04 Million |
| Selling, General and Administrative Expenses | 32.37 Million | 30.74 Million | 21.72 Million | 11.24 Million | 6.72 Million | 4.82 Million |
| Research and Development Expenses | 109.68 Million | 105.61 Million | 80.32 Million | 57.71 Million | 44.36 Million | 21.22 Million |
| Other Expenses | - | 8.25 Million | 2.49 Million | - | - | - |
| Cost and Expenses | 142.06 Million | 136.36 Million | 102.05 Million | 68.96 Million | 51.08 Million | 26.04 Million |
| Operating Income | -107.9 Million | -117.13 Million | -100.73 Million | -68.53 Million | -51.08 Million | -26.04 Million |
| Interest Expense | - | - | 1.9 Million | 979 Thousand | 540 Thousand | 371 Thousand |
| Income Tax Expense | 4.22 Million | -8255.00 | 1.9 Million | 979 Thousand | 540 Thousand | 83 Thousand |
| Earnings before Tax | -94.2 Million | -108.88 Million | -101.32 Million | -68.8 Million | -51.12 Million | -26.33 Million |
| Net Income | -98.42 Million | -108.87 Million | -103.22 Million | -69.77 Million | -51.66 Million | -26.33 Million |
| Earnings Per Share Basic | -2.34 | -2.62 | -2.78 | -1.90 | -1.40 | -1.34 |
| Earnings Per Share Diluted | -2.34 | -2.62 | -2.78 | -1.90 | -1.40 | -1.34 |
| Weighted Average Shares Outstanding | 41.97 Million | 41.59 Million | 37.17 Million | 36.79 Million | 36.81 Million | 19.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.97 Million | 41.59 Million | 37.17 Million | 36.79 Million | 36.81 Million | 19.62 Million |
| Gross Margin | -2.21 | 1.00 | -4.70 | -133.22 | - | - |
| EBIT Margin | -3.06 | -6.09 | -71.99 | -153.96 | - | - |
| Profit Margin | -2.88 | -5.66 | -78.26 | -162.28 | - | - |
| EBITDA | -104.45 Million | -113.81 Million | -96.18 Million | -66.49 Million | -48.79 Million | -25.58 Million |
| Earnings Before Tax Margin | -3.16 | -6.09 | -76.37 | -159.37 | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 7.8 Million | 6.88 Million | 5.05 Million | 34.15 Million | 5.76 Million | 17.47 Million |
| Cost of Revenue | 700 Thousand | 800 Thousand | 835 Thousand | 8.66 Million | 852 Thousand | 864 Thousand |
| Gross Profit | 7.1 Million | 6.08 Million | 4.21 Million | 25.49 Million | 4.91 Million | 16.61 Million |
| Operating Expenses | 31.66 Million | 30.32 Million | 32.4 Million | 133.4 Million | 30.37 Million | 34.55 Million |
| Selling, General and Administrative Expenses | 6.97 Million | 7.32 Million | 7.71 Million | - | 7.02 Million | 8.3 Million |
| Research and Development Expenses | 24.68 Million | 22.99 Million | 24.69 Million | - | 23.35 Million | 26.25 Million |
| Other Expenses | - | 783 Thousand | 739 Thousand | 2.83 Million | 678 Thousand | 721 Thousand |
| Cost and Expenses | 31.66 Million | 31.12 Million | 33.24 Million | 142.06 Million | 31.22 Million | 34.55 Million |
| Operating Income | -23.85 Million | -24.23 Million | -28.19 Million | -107.9 Million | -25.45 Million | -17.08 Million |
| Interest Expense | - | - | - | - | 2.26 Million | - |
| Income Tax Expense | -700 Thousand | - | 791.72 Thousand | 4.22 Million | 1.98 Million | 738 Thousand |
| Earnings before Tax | -19.12 Million | -22.97 Million | -25.01 Million | -94.2 Million | -22.12 Million | -13.6 Million |
| Net Income | -19.12 Million | -22.97 Million | -25.01 Million | -98.42 Million | -24.1 Million | -14.34 Million |
| Earnings Per Share Basic | -0.00 | -0.45 | -0.59 | - | -0.57 | -0.34 |
| Earnings Per Share Diluted | -0.00 | -0.45 | -0.59 | - | -0.57 | -0.34 |
| Weighted Average Shares Outstanding | 62.6 Billion | 51.58 Million | 42.42 Million | 41.97 Million | 42.28 Million | 42.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 62.6 Billion | 51.58 Million | 42.42 Million | 41.97 Million | 42.28 Million | 42.02 Million |
| Gross Margin | 0.91 | 0.88 | 0.83 | 0.75 | 0.85 | 0.95 |
| EBIT Margin | -3.05 | -3.40 | -5.42 | - | -4.27 | -0.93 |
| Profit Margin | -2.45 | -3.34 | -4.95 | -2.88 | -4.18 | -0.82 |
| EBITDA | -23.85 Million | -23.43 Million | -27.35 Million | - | -24.6 Million | -16.21 Million |
| Earnings Before Tax Margin | -3.05 | -3.52 | -5.58 | -3.16 | -4.41 | -0.98 |
8923
EXPO
2796
SEW
ALK
GBF